Moderna, Inc.
Moderna Outlines Next Phase of Growth at Analyst Day
Highlights intismeran and cancer antigen therapies as foundational opportunities for a growing oncology franchiseDetails commercial and manufacturing…
Company newsroom
NASDAQ:MRNA
1 releases
Highlights intismeran and cancer antigen therapies as foundational opportunities for a growing oncology franchiseDetails commercial and manufacturing…